Acadia Pharmaceuticals has received marketing authorisation from Health Canada for DAYBUE (trofinetide) to treat Rett ...

Lexicon Pharmaceuticals has entered a licensing agreement with Viatris to commercialise sotagliflozin outside the US and ...

After a hearing held on 25 September 2024, the European Patent Office (EPO) affirmed bit.bio’s claim against an anonymous ...

Seltorexant is one of J&J’s most promising neuroscience candidates. The human orexin-2 receptor selective agonist produced ...

Lilly’s senior VP of information and R&D IT Ramesh Durvasula said Lilly will use AI and tech to transform the company.

A new generation of remote monitoring devices in Scotland is helping to reduce the burden on healthcare systems and improve ...

The chronic obstructive pulmonary disease (COPD) market in the seven major markets (7MM: US, France, Germany, Italy, Spain, ...

Synedgen has announced a partnership with the Biomedical Advanced Research and Development Authority (BARDA) to develop ...

UroGen Pharma has received the NDA acceptance from the US FDA for UGN-102 (mitomycin) to treat bladder cancer.

Pfizer has announced the approval of HYMPAVZI (marstacimab-hncq) by the US Food and Drug Administration (FDA) for routine ...

Radiopharm Theranostics (RAD) and AtomVie have announced a partnership for the development and manufacturing of ...

In pharmaceutical manufacturing, viscous drug products pose unique challenges to filling efficiency and accuracy.